| . | . | RT (n = 50) . | OP (n = 50) . | P –value . |
|---|---|---|---|---|
| Age at treatment, yearsa | 53 ± 12 (26–70) | 44 ± 10 (26–67) | <0.001 | |
| Age at investigation, yearsa | 56 ± 13 (27–76) | 48 ± 10 (30–69) | 0.001 | |
| Years from treatment, yearsa | 3.2 ± 2.5 | 3.8 ± 3.7 | 0.346 | |
| Stage | I | 17 (34%) | 33 (66%) | |
| II | 33 (66%) | 17 (34%) | 0.001 | |
| Maximum tumor diameter (cm)a,* | 4.4 ± 1.04 | 3.4 ± 1.25 | 0.004 | |
| Pelvic lymph nodes metastasis ≥1 cm | ||||
| Yes | 19 (38%) | 9 (18%) | ||
| No | 31 (62%) | 41 (82%) | 0.026 | |
| PS | 0 | 43 (86%) | 46 (92%) | |
| 1 | 7 (16%) | 4 (8%) | NSe | |
| Coexisting illnessb | ||||
| Yes | 9 (18%) | 5 (10%) | ||
| No | 41 (82%) | 45 (90%) | NS | |
| Previous abdominal surgeryc | ||||
| Yes | 3(6%) | 3(6%) | ||
| No | 47 (94%) | 47(94%) | NS | |
| Marriage historyd | ||||
| Yes | 47 (94%) | 46 (92%) | ||
| No | 3 (6%) | 4 (8%) | ||
| Delivery history | ||||
| Yes | 36 (73%) | 44 (92%) | 0.018 | |
| No | 13 (27%) | 4 (8%) | ||
| Number of deliveries | 2 (0–3) | 2 (0–4) | ||
| Postoperative RT (PO-RT) | — | 29 (58%) | ||
| PO-RT alone | — | 11 (22%) | ||
| PO-RT + chemotherapy | — | 18 (36%) | ||
| Surgery alone | — | 14 (28%) | ||
| Surgery + chemotherapy | — | 7 (14%) | ||
| Combination of chemotherapy | 42 (84%) | 25 (50%) | <0.001 |
| . | . | RT (n = 50) . | OP (n = 50) . | P –value . |
|---|---|---|---|---|
| Age at treatment, yearsa | 53 ± 12 (26–70) | 44 ± 10 (26–67) | <0.001 | |
| Age at investigation, yearsa | 56 ± 13 (27–76) | 48 ± 10 (30–69) | 0.001 | |
| Years from treatment, yearsa | 3.2 ± 2.5 | 3.8 ± 3.7 | 0.346 | |
| Stage | I | 17 (34%) | 33 (66%) | |
| II | 33 (66%) | 17 (34%) | 0.001 | |
| Maximum tumor diameter (cm)a,* | 4.4 ± 1.04 | 3.4 ± 1.25 | 0.004 | |
| Pelvic lymph nodes metastasis ≥1 cm | ||||
| Yes | 19 (38%) | 9 (18%) | ||
| No | 31 (62%) | 41 (82%) | 0.026 | |
| PS | 0 | 43 (86%) | 46 (92%) | |
| 1 | 7 (16%) | 4 (8%) | NSe | |
| Coexisting illnessb | ||||
| Yes | 9 (18%) | 5 (10%) | ||
| No | 41 (82%) | 45 (90%) | NS | |
| Previous abdominal surgeryc | ||||
| Yes | 3(6%) | 3(6%) | ||
| No | 47 (94%) | 47(94%) | NS | |
| Marriage historyd | ||||
| Yes | 47 (94%) | 46 (92%) | ||
| No | 3 (6%) | 4 (8%) | ||
| Delivery history | ||||
| Yes | 36 (73%) | 44 (92%) | 0.018 | |
| No | 13 (27%) | 4 (8%) | ||
| Number of deliveries | 2 (0–3) | 2 (0–4) | ||
| Postoperative RT (PO-RT) | — | 29 (58%) | ||
| PO-RT alone | — | 11 (22%) | ||
| PO-RT + chemotherapy | — | 18 (36%) | ||
| Surgery alone | — | 14 (28%) | ||
| Surgery + chemotherapy | — | 7 (14%) | ||
| Combination of chemotherapy | 42 (84%) | 25 (50%) | <0.001 |
aMeans and standard deviations, otherwise numbers and proportions.
bE.g. diabetes mellitus, hypertension.
cE.g. appendectomy.
dIncluding common-law marriage.
eNS = not significant.
| . | . | RT (n = 50) . | OP (n = 50) . | P –value . |
|---|---|---|---|---|
| Age at treatment, yearsa | 53 ± 12 (26–70) | 44 ± 10 (26–67) | <0.001 | |
| Age at investigation, yearsa | 56 ± 13 (27–76) | 48 ± 10 (30–69) | 0.001 | |
| Years from treatment, yearsa | 3.2 ± 2.5 | 3.8 ± 3.7 | 0.346 | |
| Stage | I | 17 (34%) | 33 (66%) | |
| II | 33 (66%) | 17 (34%) | 0.001 | |
| Maximum tumor diameter (cm)a,* | 4.4 ± 1.04 | 3.4 ± 1.25 | 0.004 | |
| Pelvic lymph nodes metastasis ≥1 cm | ||||
| Yes | 19 (38%) | 9 (18%) | ||
| No | 31 (62%) | 41 (82%) | 0.026 | |
| PS | 0 | 43 (86%) | 46 (92%) | |
| 1 | 7 (16%) | 4 (8%) | NSe | |
| Coexisting illnessb | ||||
| Yes | 9 (18%) | 5 (10%) | ||
| No | 41 (82%) | 45 (90%) | NS | |
| Previous abdominal surgeryc | ||||
| Yes | 3(6%) | 3(6%) | ||
| No | 47 (94%) | 47(94%) | NS | |
| Marriage historyd | ||||
| Yes | 47 (94%) | 46 (92%) | ||
| No | 3 (6%) | 4 (8%) | ||
| Delivery history | ||||
| Yes | 36 (73%) | 44 (92%) | 0.018 | |
| No | 13 (27%) | 4 (8%) | ||
| Number of deliveries | 2 (0–3) | 2 (0–4) | ||
| Postoperative RT (PO-RT) | — | 29 (58%) | ||
| PO-RT alone | — | 11 (22%) | ||
| PO-RT + chemotherapy | — | 18 (36%) | ||
| Surgery alone | — | 14 (28%) | ||
| Surgery + chemotherapy | — | 7 (14%) | ||
| Combination of chemotherapy | 42 (84%) | 25 (50%) | <0.001 |
| . | . | RT (n = 50) . | OP (n = 50) . | P –value . |
|---|---|---|---|---|
| Age at treatment, yearsa | 53 ± 12 (26–70) | 44 ± 10 (26–67) | <0.001 | |
| Age at investigation, yearsa | 56 ± 13 (27–76) | 48 ± 10 (30–69) | 0.001 | |
| Years from treatment, yearsa | 3.2 ± 2.5 | 3.8 ± 3.7 | 0.346 | |
| Stage | I | 17 (34%) | 33 (66%) | |
| II | 33 (66%) | 17 (34%) | 0.001 | |
| Maximum tumor diameter (cm)a,* | 4.4 ± 1.04 | 3.4 ± 1.25 | 0.004 | |
| Pelvic lymph nodes metastasis ≥1 cm | ||||
| Yes | 19 (38%) | 9 (18%) | ||
| No | 31 (62%) | 41 (82%) | 0.026 | |
| PS | 0 | 43 (86%) | 46 (92%) | |
| 1 | 7 (16%) | 4 (8%) | NSe | |
| Coexisting illnessb | ||||
| Yes | 9 (18%) | 5 (10%) | ||
| No | 41 (82%) | 45 (90%) | NS | |
| Previous abdominal surgeryc | ||||
| Yes | 3(6%) | 3(6%) | ||
| No | 47 (94%) | 47(94%) | NS | |
| Marriage historyd | ||||
| Yes | 47 (94%) | 46 (92%) | ||
| No | 3 (6%) | 4 (8%) | ||
| Delivery history | ||||
| Yes | 36 (73%) | 44 (92%) | 0.018 | |
| No | 13 (27%) | 4 (8%) | ||
| Number of deliveries | 2 (0–3) | 2 (0–4) | ||
| Postoperative RT (PO-RT) | — | 29 (58%) | ||
| PO-RT alone | — | 11 (22%) | ||
| PO-RT + chemotherapy | — | 18 (36%) | ||
| Surgery alone | — | 14 (28%) | ||
| Surgery + chemotherapy | — | 7 (14%) | ||
| Combination of chemotherapy | 42 (84%) | 25 (50%) | <0.001 |
aMeans and standard deviations, otherwise numbers and proportions.
bE.g. diabetes mellitus, hypertension.
cE.g. appendectomy.
dIncluding common-law marriage.
eNS = not significant.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
